All In MedTech

FDA Clearance Tracker · P240044

Globe® Pulsed Field System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Aug 27, 2025 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 27, 2025

Approved

Time to decision

253 days

Received Dec 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P240044
Device name
Globe® Pulsed Field System
Applicant
Kardium, Inc.
Applicant location
Burnaby
Received
Dec 17, 2024
Decided
Aug 27, 2025
Decision
Approved
Supplements
8 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QZI

FDA's approval statement

As written in FDA's record.

approval for the Globe® Pulsed Field System. This device is indicated for: The Globe® Catheter is indicated for anatomical and electrophysiological mapping and stimulation of cardiac tissue, and for the delivery of ablation energy for the treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation, when used in conjunction with the Globe Pulsed Field System. The Globe® PF System is indicated for catheter-based cardiac anatomical and electrophysiological mapping and stimulation of cardiac tissue.When used for pulsed field ablation, refer to the Instructions for Use of the compatible cardiac ablation catheter for the specific indications for use.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code QZI. The earliest in FDA's data is P230017, decided Dec 13, 2023.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Kardium, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.